Joinn Laboratories(China)Co - Asset Resilience Ratio

Latest as of March 2026: 15.05%

Joinn Laboratories(China)Co (603127) has an Asset Resilience Ratio of 15.05% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Joinn Laboratories(China)Co to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.51 Billion

≈ $221.09 Million USD Cash + Short-term Investments

Total Assets

CN¥10.04 Billion

≈ $1.47 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Joinn Laboratories(China)Co's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Joinn Laboratories(China)Co's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Joinn Laboratories(China)Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Joinn Laboratories(China)Co balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.51 Billion	15.05%
Total Liquid Assets	CN¥1.51 Billion	15.05%

Asset Resilience Insights

Good Liquidity Position: Joinn Laboratories(China)Co maintains a healthy 15.05% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Joinn Laboratories(China)Co Industry Peers by Asset Resilience Ratio

Compare Joinn Laboratories(China)Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Prodia Widyahusada Tbk PT JK:PRDA	Diagnostics & Research	7.82%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Check Cap Ltd NASDAQ:CHEK	Diagnostics & Research	70.29%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Joinn Laboratories(China)Co (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Joinn Laboratories(China)Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	17.75%	CN¥1.72 Billion ≈ $251.44 Million	CN¥9.68 Billion ≈ $1.42 Billion	+2.89pp
2024-12-31	14.86%	CN¥1.40 Billion ≈ $204.30 Million	CN¥9.40 Billion ≈ $1.37 Billion	+11.14pp
2023-12-31	3.72%	CN¥373.35 Million ≈ $54.63 Million	CN¥10.03 Billion ≈ $1.47 Billion	-0.22pp
2022-12-31	3.94%	CN¥408.47 Million ≈ $59.77 Million	CN¥10.36 Billion ≈ $1.52 Billion	-4.04pp
2021-12-31	7.98%	CN¥680.98 Million ≈ $99.65 Million	CN¥8.54 Billion ≈ $1.25 Billion	-3.36pp
2020-12-31	11.33%	CN¥238.90 Million ≈ $34.96 Million	CN¥2.11 Billion ≈ $308.44 Million	+2.12pp
2019-12-31	9.22%	CN¥130.70 Million ≈ $19.13 Million	CN¥1.42 Billion ≈ $207.47 Million	+0.21pp
2018-12-31	9.01%	CN¥102.85 Million ≈ $15.05 Million	CN¥1.14 Billion ≈ $167.02 Million	+8.96pp
2017-12-31	0.06%	CN¥519.97K ≈ $76.09K	CN¥940.87 Million ≈ $137.68 Million	--

pp = percentage points

About Joinn Laboratories(China)Co

SHG:603127 China Diagnostics & Research

Market Cap

$4.25 Billion

CN¥29.07 Billion CNY

Market Cap Rank

#3989 Global

#591 in China

Share Price

CN¥46.12

Change (1 day)

-1.33%

52-Week Range

CN¥26.50 - CN¥53.90

All Time High

CN¥175.47